4/25/2012
Quidel Reports First Quarter 2012 Financial Results
READ MORE

4/20/2012
Quidel Receives CLIA Waiver for Its Sofia(TM) Analyzer and Sofia Influenza A+B Fluorescent Immunoassay (FIA)
READ MORE



Announcing - Quidel Sofia

By building value in rapid diagnostic tests, Quidel provides leadership to the industry and health care professionals allowing for the movement of patient testing out of the central laboratory setting and into the physician office, urgent care and other outpatient settings where rapid testing and treatment has an impact on clinical outcomes and provides an economic benefit.

rapid diagnostics

We provide easy to use, rapid diagnostic solutions, on a worldwide basis. Our rapid tests are used to more effectively triage patients in acute care facilities and physicians offices.

Evaluate Kit
specialty products group

Our goal is to deliver first-to-market products that provide a specialized value-added benefit of lowering overall health care costs and improving the quality of health care today.